Page last updated: 2024-09-05

sb 203580 and malformins

sb 203580 has been researched along with malformins in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(malformins)
Trials
(malformins)
Recent Studies (post-2010) (malformins)
3,48941,1371707

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, SB; Joo, YE; Lee, WS; Myung, DS; Oh, HH; Park, D; Park, SY; Park, YL; Yu, HM1

Other Studies

1 other study(ies) available for sb 203580 and malformins

ArticleYear
MalforminĀ A1 treatment alters invasive and oncogenic phenotypes of human colorectal cancer cells through stimulation of the p38 signaling pathway.
    International journal of oncology, 2017, Volume: 51, Issue:3

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Survival; Colorectal Neoplasms; DNA Fragmentation; Humans; Imidazoles; MAP Kinase Signaling System; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Peptides, Cyclic; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins; Pyridines; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein

2017